HIV molecular immunology database
IRYQYNVLPQGWKGSPAI
|
Pol(297-314) | human epitope |
YNVLPQGWKGSPAIF
|
Pol(301-315) | human epitope |
LPQGWKGSPA
|
Pol(304-313) | B*54:01 human epitope |
LPQGWKGSPA
|
Pol(304-313) | B*54:01 human epitope |
LPQGWKGSPA
|
Pol(304-313) | human epitope |
LPQGWKGSPs
|
Pol(304-313) | replicative capacity reduced |
LPQGWKGSPA
|
Pol(304-313) | human epitope |
LPQGWKGSPAI
|
Pol(304-314) | B*39:10 human epitope |
LPQGWKGSPAI
|
Pol(304-314) | B*42:01 human epitope |
PQGWKGSPAIFQSSM
|
Pol(305-319) | human epitope |
KQGWKGSPAIFQSSMT
|
Pol(305-320) | human epitope |
PQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVG
|
Pol(305-345) | mouse epitope |
QGWKGSPAI
|
Pol(306-314) | B*51:01 human epitope |
QGWKGaPAI
|
Pol(306-314) | observed variant |
QGWKGSPAI
|
Pol(306-314) | human epitope |
QGWKGSPAIFQSSMTKIL
|
Pol(306-323) | C*12 human epitope |
QGWKGSPAIFQSSMTKIL
|
Pol(306-323) | human epitope |
QGWKGSPAIFQSSMTKIL
|
Pol(306-323) | human epitope |
QGWKGSPAIFQaSMTKIL
|
Pol(306-323) | susceptible form |
WKGSPAIFQSSMT
|
Pol(308-320) | B7 human epitope |
WKGSPAIFQSSMT
|
Pol(308-320) | B7 human epitope |
WKGSPAIFQSSMTKI
|
Pol(308-322) | human epitope |
KGSPAIFQSSM
|
Pol(309-319) | B*07 human epitope |
KGSPAIFQSSMTKIL
|
Pol(309-323) | human epitope |
GSPAIFQSS
|
Pol(310-318) | human epitope |
GSPAIFQSSMTKILE
|
Pol(310-324) | macaque epitope |
GSPAIFQSSMTKILE
|
Pol(310-324) | human epitope |
GSPAIFQSSMTKILE
|
Pol(310-324) | human epitope |
GSPAIFQSSMTKILE
|
Pol(310-324) | human epitope |
GSPAIFQSSMTKILE
|
Pol(310-324) | human epitope |
SPAIFQSSM
|
Pol(311-319) | A*30 human epitope |
SPAIFQSSM
|
Pol(311-319) | A*68:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQCSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQSSM{TKILd}
|
Pol(311-319) | escape documented in this paper; processing |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQcSM
|
Pol(311-319) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
SPAIFQaSM
|
Pol(311-319) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
SPAIFQSSM
|
Pol(311-319) | B*07:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02, B*35:01 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*07:02, B*81:01 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*15:17 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*35 human epitope |
SPAIFQSSM
|
Pol(311-319) | B35 human epitope |
SPAIFQSSM
|
Pol(311-319) | B35 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*35:01 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*39 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*42:01 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*42:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*42:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B*42:02 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | B7 human epitope |
SPAIFQSSM
|
Pol(311-319) | C*08 human epitope |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPsIFQSSM
|
Pol(311-319) | susceptible form |
SPAIFQcSM
|
Pol(311-319) | susceptible form |
SPAIFQaSM
|
Pol(311-319) | susceptible form |
SPsIFQcSM
|
Pol(311-319) | non-susceptible form; susceptible form |
SPAIFaSSM
|
Pol(311-319) | non-susceptible form; susceptible form |
SPAaFQSSM
|
Pol(311-319) | non-susceptible form |
SPAIaQSSM
|
Pol(311-319) | non-susceptible form |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPsIFQSSM
|
Pol(311-319) | replicative capacity reduced |
SPAIFQSSM
|
Pol(311-319) | human epitope |
SPSIFQSSM
|
Pol(311-319) | human epitope |
SPAIFQSSMT
|
Pol(311-320) | B*07 human epitope |
SPAIFQSSMT
|
Pol(311-320) | B*07 human epitope |
SPAIFQSSMT
|
Pol(311-320) | B*07 human, transgenic mouse epitope |
SPAIFQSSMT
|
Pol(311-320) | B35 human epitope |
SsPAIFQSSMT
|
Pol(311-320) | literature escape; non-susceptible form |
SPAIFQSSMT
|
Pol(311-320) | B7 human epitope |
SPAIFQxSMT
|
Pol(311-320) | calculated escape |
SPAIFQSSMT
|
Pol(311-320) | B7 human epitope |
SPAIFQSSMT
|
Pol(311-320) | B7 human epitope |
SPAIFQSSMT
|
Pol(311-320) | B7 human epitope |
SPAIFQSSMTK
|
Pol(311-321) | A*03, A*11, A*33, A*68:01, B*07, B*35 human epitope |
SPAIFQSSMTK
|
Pol(311-321) | A*11:01 human epitope |
SPAIFQSSMTK
|
Pol(311-321) | A*11:01 human epitope |
SPAIFQSSMTK
|
Pol(311-321) | B*07:02 human epitope |
SPAIFQSSMTK
|
Pol(311-321) | B*07:02 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03, A*11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03, A*11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03, A*11 human epitope |
AIFQCSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQsSMTr
|
Pol(313-321) | diminished response; escape documented in this paper; non-susceptible form |
AIFQsSMTK
|
Pol(313-321) | non-susceptible form |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01, A*68:01, A11, A3, A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01, A11, A33 human, macaque epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01, A11, A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*03:01, A*11:01, A*68:01, A3 human epitope |
AIFQcSMTK
|
Pol(313-321) | susceptible form |
AIFQSSMTt
|
Pol(313-321) | diminished HLA binding or increased off-rate; non-susceptible form |
AIFQrSMTr
|
Pol(313-321) | diminished HLA binding or increased off-rate; susceptible form |
AIlQSSMTr
|
Pol(313-321) | diminished response; susceptible form |
AIFQSSMTr
|
Pol(313-321) | susceptible form |
sIFQSSMTK
|
Pol(313-321) | susceptible form |
AIFQSSMTK
|
Pol(313-321) | A03 supertype human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTr
|
Pol(313-321) | escape documented in this paper |
tIFQSSMTr
|
Pol(313-321) | observed variant |
AIFQSSMar
|
Pol(313-321) | observed variant |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
SIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTx
|
Pol(313-321) | calculated escape |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11, A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11, A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11, A3 human epitope |
SIFQSSMTK
|
Pol(313-321) | A11, A3, A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11, A3, A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A11, A3, A33, A68 epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A*11:01 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQaSMTK
|
Pol(313-321) | diminished response; subtype-specific susceptible form |
sIFQSSMTK
|
Pol(313-321) | subtype-specific susceptible form |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTr
|
Pol(313-321) | susceptible form |
AIFlSSMTK
|
Pol(313-321) | escape documented in this paper |
tIsQSSMTK
|
Pol(313-321) | escape documented in this paper |
AIlQSSMTK
|
Pol(313-321) | observed variant |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMlK
|
Pol(313-321) | non-susceptible form |
AIFQSSMTK
|
Pol(313-321) | A3 human epitope |
AIFQSSMTK
|
Pol(313-321) | A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A33 human epitope |
AIFQSSMTK
|
Pol(313-321) | A3 supertype human, mouse epitope |
AIFQSSMTK
|
Pol(313-321) | A3 supertype human epitope |
AIFQSSMTK
|
Pol(313-321) | A*68:01 human epitope |
AIFQCSMTK
|
Pol(313-321) | human epitope |
AIFQsSMTK
|
Pol(313-321) | observed variant |
AIFQSSMTK
|
Pol(313-321) | human epitope |
sIFQSSMTK
|
Pol(313-321) | replicative capacity reduced |
AIFQSSMTK
|
Pol(313-321) | human epitope |
SIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTK
|
Pol(313-321) | human epitope |
AIFQSSMTKILEPFR
|
Pol(313-327) | human epitope |
AIFQSSMTKILEPFRKQN
|
Pol(313-330) | human epitope |
AIFQSSMTKILEPFRKQNPDIVIYQ
|
Pol(313-337) | A11 human epitope |
AIFQSSMTKILEPFRKQNPDIVIYQ
|
Pol(313-337) | A11 human epitope |
IFQSSMTKI
|
Pol(314-322) | H-2Kd mouse epitope |
IFQaSMTKI
|
Pol(314-322) | susceptible form |
IFQcSMTKI
|
Pol(314-322) | diminished response |
IFQSSMTKI
|
Pol(314-322) | H-2Kd mouse epitope |
IFQSSMTKI
|
Pol(314-322) | H-2Kd mouse epitope |
IFgSSMTKa
|
Pol(314-322) | diminished HLA binding or increased off-rate |
IFQSSMTKI
|
Pol(314-322) | H-2d human, mouse epitope |
IFQSSMTKI
|
Pol(314-322) | H-2d mouse epitope |
IFQSSMTKI
|
Pol(314-322) | mouse epitope |
IFQSSMTKIL
|
Pol(314-323) | human epitope |
IFQSSMTKILEPFRA
|
Pol(314-328) | macaque epitope |
IFQSSMTKILEPFRA
|
Pol(314-328) | human epitope |
SMTKILEPF
|
Pol(318-326) | human epitope |
SMTKILEPFRAQNPE
|
Pol(318-332) | human epitope |
MTKILEPFR
|
Pol(319-327) | A*03:01 human epitope |
MTKILdPFR
|
Pol(319-327) | diminished HLA binding or increased off-rate; escape documented in this paper |
MTKILEPFR
|
Pol(319-327) | A3 supertype human epitope |
MTKILEPFR
|
Pol(319-327) | human epitope |
KILEPFRKQNPDIVIYQY
|
Pol(321-338) | human epitope |
KILEPFRKQNPDIVIYQY
|
Pol(321-338) | human epitope |